IT1165451B - Virus vaccinico modificato e metodi per la produzione ed uso del medesimo - Google Patents

Virus vaccinico modificato e metodi per la produzione ed uso del medesimo

Info

Publication number
IT1165451B
IT1165451B IT21041/83A IT2104183A IT1165451B IT 1165451 B IT1165451 B IT 1165451B IT 21041/83 A IT21041/83 A IT 21041/83A IT 2104183 A IT2104183 A IT 2104183A IT 1165451 B IT1165451 B IT 1165451B
Authority
IT
Italy
Prior art keywords
genome
vaccinia
dna
vaccinia virus
virus
Prior art date
Application number
IT21041/83A
Other languages
English (en)
Other versions
IT8321041A0 (it
Inventor
Enzo Paoletti
Dennis Panicali
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/446,824 external-priority patent/US4603112A/en
Application filed by Health Research Inc filed Critical Health Research Inc
Publication of IT8321041A0 publication Critical patent/IT8321041A0/it
Application granted granted Critical
Publication of IT1165451B publication Critical patent/IT1165451B/it

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT21041/83A 1982-12-08 1983-05-11 Virus vaccinico modificato e metodi per la produzione ed uso del medesimo IT1165451B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/446,824 US4603112A (en) 1981-12-24 1982-12-08 Modified vaccinia virus

Publications (2)

Publication Number Publication Date
IT8321041A0 IT8321041A0 (it) 1983-05-11
IT1165451B true IT1165451B (it) 1987-04-22

Family

ID=23773961

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21041/83A IT1165451B (it) 1982-12-08 1983-05-11 Virus vaccinico modificato e metodi per la produzione ed uso del medesimo

Country Status (1)

Country Link
IT (1) IT1165451B (it)

Also Published As

Publication number Publication date
IT8321041A0 (it) 1983-05-11

Similar Documents

Publication Publication Date Title
ES2158867T3 (es) Dna que codifica mutantes de aspartoquinasa iii y su uso para la produccion de l-treonina por fermentacion.
UA42089C2 (uk) Протигрипозна вакцина на основі поверхневого антигену, спосіб її виробництва
NZ222792A (en) Process for genetically transforming plant protoplasts
ES2072892T3 (es) Proteina receptora para un factor 2 estimulante de celulas b humanas.
EP0752874A4 (en) A STRENGTHENED VIRUS-TRANSFERED DNA TRANSFER
DE69720026D1 (de) Verfahren zur herstellung von d-aminosäuren durch direkte gärung
DE3164143D1 (en) Production of viral antigens
FR2581394B1 (fr) Particules ayant les proprietes immunogenes de l'antigene hbs et portant un site antigenique etranger aux epitopes portes par l'antigene hbs, vecteurs et cellules animales pour la production de telles particules et compositions contenant de telles particules pour la production de vaccins mixtes
KR890014740A (ko) 재조합 마렉병 비루스 및 백신
ATE301707T1 (de) Aus einer mit einem stamm von multiple-sklerosis- virus infizierten zellinie hergestelltes biologisches virusmaterial
ATE73349T1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
IT1165451B (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo
CN109055398A (zh) 一种包含密码子优化cfp10基因的结核dna疫苗
ATE100495T1 (de) Rekombinantes marek-krankheitsvirus, verfahren zu seiner herstellung, und vakzine.
DE3588117D1 (de) Zubereitung für die Herstellung von Hepatitis B Virus-Oberflächenantigen und polymerisierten Humanserumalbuminrezeptor tragende Partikel enthaltenden Vakzinen, tierische Zellen für die Herstellung von diesen Partikeln und Verfahren für ihre Erhaltung
IL79432A (en) Unicellular microorganisms having invasive capability due to exogenous inv gene and vaccines comprising such microorganisms
ES2053766T3 (es) Metodo para aumentar la expresion de un gen.
KR950700329A (ko) 신규한 세포 표층 단백질(Novel cell cortex protein)
KR880007728A (ko) 비루스 벡터 및 재조합 dna
Lasky et al. Production of an HSV subunit vaccine by genetically engineered mammalian cell lines.
Mizrahi Biologicals produced from animal cells in culture—an overview
KR860008281A (ko) 간염 b형 표면 항원을 암호하는 재조합 dna벡터
TW280832B (it)
Wu Studies on the Cultivation of Human Diploid Cells in Microcarrier Culture.
Tikhonenko Prospects and achievements in the development of genetically engineered antiviral vaccines.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971223